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ABSTRACT A gene, PDE2, has been cloned from the yeast
Saccharomyces cerevisiae that, when present in high copy,
reverses the phenotypic effects of RAS2vad9, a mutant form of
the RAS2 gene that renders yeast cells sensitive to heat shock
and starvation. It has previously been shown that the RAS
proteins are potent activators of yeast adenylate cyclase. We
report here that PDE2 encodes a high-affinity cAMP phospho-
diesterase that shares sequence homology with animal cell
phosphodiesterases. These results therefore imply that the
effects of RAS2vi19 are mediated through its changes in cAMP
concentration.
Our laboratory group has been studying the mechanism of
growth control in the yeast Saccharomyces cerevisiae with
particular concentration on the functions of the RAS] and
RAS2 genes, which are structurally and functionally homol-
ogous to the ras oncogenes ofmammalian cells (1-4). At least
one RASI or RAS2 gene is required for the continued growth
of yeast cells (5, 6) and it has been shown that RAS genes are
essential controlling elements for adenylate cyclase in yeast
(2, 7, 8). A mutant RAS2 gene has been constructed that
encodes valine at the 19th codon position instead of glycine
(5). This mutant (RAS2vall9) is analogous to the mutant and
oncogenic human Ha-ras gene, which was first recognized in
the T24/EJ bladder cell line (9-11). Yeast cells that express
the mutant RAS2vall9 gene fail to synthesize glycogen, show
an abnormal sensitivity to starvation (8), show a defective
ability to arrest in the G1 phase of the cell cycle (8), and are
sensitive to heat shock (unpublished results). To better
understand the mechanism of these effects, we have searched
for yeast genes that, when present in high copy, reverse these
phenotypic effects. One such gene has been found, and it
encodes the high-affinity cAMP phosphodiesterase (PDEase)
of S. cerevisiae. We here present the nucleotide sequence of
this gene and describe some of the phenotypic consequences
of its perturbation.
METHODS
Yeast Strains, Growth Media, Transformation, Heat Shock,
and Starvation. Growth and general genetic manipulation of
yeast cells was carried out as described (12). Tetrad dissec-
tions and assignment of auxotrophic markers were performed
as described (1, 5). A genomic library that had been con-
structed in the plasmid vector YEp13 from yeast DNA
partially digested with Sau3A restriction endonuclease has
been described previously (13, 14). YEp13 is an extrachro-
mosomally replicating plasmid that contains the 2-,um origin
of replication, the LEU2 gene, and parts of pBR322 (14).
Transformation into yeast cells was carried out using lithium
acetate (15). Yeast cells were heat shocked and starved for
nitrogen by a replica plating method. Heat shock was
performed by replica plating cells that had grown for 2 days
at 30'C on selective medium to a medium that had been
heated for 1 hr at 550C. After a 30-min incubation at 550C this
replica was transferred to a 30'C incubator for 2 days and then
scored for growth. Yeast were starved for nitrogen by replica
plating cells that had been grown for 2 days on selective plates
at 30°C to plates that lacked a source of nitrogen (8). This
replica was incubated at 30°C for 7 days, then replica plated
onto rich medium and grown for 2 days at 30°C, and then
scored.
Plasmid Constructions and DNA Sequencing. The cloning
and structure of the PDE2 gene and ppde2: :URA3 disruption
plasmids are described below and in Fig. 1. Yeast DNA was
prepared as described (16). Restriction endonuclease frag-
ments were cloned into M13mpl8 or M13mpl9 vectors (17)
and sequenced by a modification of the dideoxy chain-
termination method (18, 19).
PDEase Assays. Yeast cells were lysed by passage through
a French press at 20,000 psi (1 psi = 6.89 kPa). Extracts were
centrifuged at 1600 x g for 10 min and the resulting super-
natant was centrifuged at 22,000 x g for 90 min. The crude
yeast extract was loaded onto a DEAE-Sephacel column and
eluted with a 200-ml linear gradient as described (20). cAMP
PDEase was assayed by a modification (21) of the procedure
of Kuo et al. (22, 23).
RESULTS
A Gene in High Copy That Reverts the RAS2v"19 Phenotype.
Cell strains containing the RAS2vall9 allele have been de-
scribed (8). The strain TK161-R2V (see Table 1 for strain list)
shows all the characteristics typical of strains containing the
RAS2vall9 allele. In particular, cells ofthis strain are sensitive
to heat shock, lose viability on starvation, and fail to
accumulate glycogen. This strain was transformed with
pooled DNA from a library of S. cerevisiae chromosomal
DNA carried on the YEpl3 shuttle vector, which contains the
LEU2 gene and the f3-lactamase gene (13, 14). Leu+ trans-
formants were selected and tested for heat shock sensitivity
by a replica plate method. Several heat shock-resistant
colonies were observed in the first screening, and cells from
these colonies showed this phenotype only when they re-
tained the LEU2 marker. Plasmids from two of these strains
were used to transform Escherichia coli to ampicillin resist-
ance. Restriction endonuclease maps of both plasmids indi-
cated that they contained inserts from the same locus (Fig.
la). Subcloning experiments helped to delineate the func-
tional gene (Fig. lb), which was then sequenced on both
strands by the dideoxy chain-termination method (Fig. ic).
The nucleotide sequence of this gene is presented in Fig. 2
together with the predicted amino acid sequence of its
encoded product. The largest open reading frame initiated by
Abbreviations: PDEase, phosphodiesterase; kb, kilobase(s).
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Table 1. Strains used
Strain Genotype and derivation
TK161-R2V* MATa leu2 his3 ura3 trpl ade8 can) RAS2valL9
R2V-YEpl3 Transformant of TK161-R2V that contains YEp13
R2V-PDE2 Transformant of TK161-R2V that contains YEpPDE2-1
SPD-12 MATa/MATa leu2/leu2 his3/+ his4/+ ura3/ura3 trpl/trpl ade8/ade8 canl/+
PN1-i Transformant of diploid strain SPD-12 with the 5.1-kb BamHI fragment of
ppde2::URA3
PS-1B MATa leu2 his3 ura3 pde2::URA3 trpl ade8 (segregant from PS1-i)
PS1-iBY Transformant of PS1-lB that contains YEpPDE2-1
PS1-1BYL Derived from PSi-1BY by loss of YEpPDE2-1
SP1* MATa leu2 his3 ura3 trpl ade8 can)
SP1-YEp13 Transformant of SP1 that contains YEp13
SP1-PDE2 Transformant of SP1 that contains YEpPDE2-1
*From ref. 8.
ATG is 526 codons long. An in-frame stop codon appears nine
nucleotides 5' to this ATG. This gene can thus encode a
protein of 60,910 daltons. Computer-assisted sequence com-
parisons showed no similarities between this sequence and
any other published sequence (24). However, since RAS2val19
strains have high levels ofcAMP and since our gene reverses
the RAS2vall9 phenotype, we considered whether our gene
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FIG. 1. Structure, sequencing strategy, and disruption of the
PDEase gene. (a) Restriction cleavage maps ofplasmids YEpPDE2-1
and YEpPDE2-2. (b) Subcloning strategy used to locate the PDE2
gene. Restriction fragments that were active in suppressing the heat
shock-sensitive phenotype of the RAS2v`l9 mutation are denoted by
a +, inactive fragments, by a -. (c) Strategy used for sequencing the
PDE2 gene (hatched boxes represent coding sequences) using some
of the restriction sites shown in a. Open circles and arrows indicate
starting sites, directions, and ranges of sequencing by the M13
dideoxy nucleotide sequencing method (21, 22). (d) Disruption of the
PDE2 coding sequences by insertion of the 1.1-kb URA3 gene into
the unique Hpa I restriction endonuclease site. Abbreviations used:
B, BamHI; Bl, Bal I, Bg, Bgl II; D, Dra I; E, EcoRI; H3, HindIII;
Hp, Hpa I; P, Pst I; Sp, Sph I; T, Taq I. J represents a junction
between an insert DNA and a BamHI cleavage site of the vector
YEp13. The squiggly lines indicate vector sequences.
might encode a cAMP PDEase. Biochemical analysis had
previously indicated that there are at least two cAMP
PDEases in yeast, one with low affinity and broad specificity
and one with high affinity and narrow specificity (25, 26). The
amino acid compositions of these enzymes have been pub-
lished. Table 2 shows a comparison of the amino acid
composition of our predicted gene product with these
PDEases. There is a striking similarity in amino acid com-
position between our protein and the high-affinity cAMP
PDEase. The major differences are in those amino acids that
are the most difficult to quantitate accurately, namely,
methionine, cysteine, and proline. Moreover, the high-
affinity cAMP PDEase of yeast is estimated to be 61,000
daltons, in excellent agreement with the predicted molecular
mass of our gene product. For these reasons we tentatively
named our gene PDE2. This nomenclature is justified by the
experiments below.
PDE2 Encodes a High-Afflinity cAMP PDEase. A direct
biochemical approach was taken to test whether indeed
PDE2 encodes a high-affinity cAMP PDEase. For this pur-
pose, we constructed yeast strains carrying multiple copies of
the PDE2 gene and strains with a disrupted PDE2 gene. To
disrupt the PDE2 gene, we first inserted the URA3 marker
into the unique Hpa I restriction endonuclease site ofplasmid
pPDE2 (Fig. ld). This causes a disruption between the 261st
and 262nd codons of PDE2. The 5.1-kilobase (kb) BamHI
fragment was then used to transform the diploid strain
SPD-12. (See Table 1 for a description of yeast strains.)
Southern blotting indicated that one allele ofPDE2 had been
disrupted in a resulting transformant called PS1-1. This
diploid was sporulated, giving rise to viable haploid progeny
containing the URA3 marker. One of the resulting URA3'
progeny was then transformed with plasmid YEpPDE2-1
(Fig. la) to provide the PDE2 gene on a high-copy extra-
chromosomally replicating plasmid. One transformant strain,
PSi-1BY, was used in subsequent experiments. To obtain
isogenic PDE2' and pde2- strains, strain PSl-lBYL was
obtained from PSl-iBY by removal ofthe high-copy plasmid.
Strains PSi-iBY, PS1-iBYL, and the wild-type haploid
strain SP1 were then analyzed biochemically.
Hydrolysis of cAMP was measured by a modification (21)
of the method of Kuo et al. (22, 23). Assays for cAMP
PDEase used cAMP concentrations in the micromolar range
and hence measured predominantly, but not entirely, the low
Km or high-affinity form of PDEase (26). Perhaps because of
this, the crude yeast cell extracts showed variable levels of
PDEase activity even in strains lacking PDE2 (data not
shown). We therefore fractionated the crude extracts to
separate high-affinity and low-affinity forms of PDEase. The
crude cellular extracts were chromatographed on DEAE-
Sephacel columns, eluting with NaCl gradients according to
the method of Uno et al. (20). The PDEase activity profile of
the fractions obtained showed the following results: (i) a peak
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-105 CCTCTTTATCTTTTGCACTGACGCTTTATTAGCCACTAATTAGAGTATCCAGACATTCTTTTTGAGATCACTACTACTTAATTGAAGAA
1 oM.Met Ser Thr Leu Phe Lou lie Gly lie His Glu lie Glu Lys Ser Gin Thr le Val Gin Asn Glu His Tyr Phe
-16 AACATAA CCT ATT GAT ATG TCC ACC CTT TTT CTG ATT GGA ATA CAC GAG ATT GAG MA TCT CM ACA ATT GTA CAG MT GM CAC TAT TTT
26 Asp Arg Val lie Glu Leu Gin Asp Leu Asp Ser Lou Met Val Ala Leu Tyr Lys Asp Arg Val Ser Pro Phe Pro Asn Val His Asn Phe
76 GAT AGA GTG ATT GAG CTT CAA GAT TTG GAT TCT CTG ATG GTA GCA TTG TAT AMG GAC AGA GTT TCG CCT TTT CCA AAC GTC CAT AAC TTT
56 Glu Thr Gly Vol Ser lie Vol Leu Tyr Asp Pro Ser Lys Phe Gin Leu Ser Vol Arg Gin Lou Asp Vol Lou Phe Lys Gly Phe Phe Pro
166 GAA ACG GGC GTA TCT ATA GTT CTT TAT GAC CCT TCA AM TTT CM TTA TCT GTG CGA CAA TTG GAT GTT CTA TTC MG GGA TTT TTC CCA
86 Ser Phe Asn Ile Ser Ala Ile Asp His Thr Arg Glu Glu Asn Lou Gin Arg Lou Glu Cys Val Glu Arg Glu Asn Ser Ile Cys Arg Asn
256 TCT TTC MT ATT TCT GCG ATA GAT CAT ACA CGA GAG GM MC CTG CAA CGT CTG GM TGT GTT GAG CGT GAA MT AGC ATC TGT CGT MT
116 Arg Ile Thr Arg lie Asn His Trp Met Tyr His His His Asp Asp Thr Pro Asp Gly lie Asn Lys Asn Ser Tyr Gly Thr Vol Asn Gly
346 AGA ATA ACG AGA ATT MC CAC TGG ATG TAT CAC CAT CAT GAT GAT ACT CCA GAC GGT ATT MC MA MC AGC TAT GGT ACT GTA AAT GGG
146 Asn Ser Vol Pro Thr Gin Ala Cys Glu Ala Asn lie Tyr Thr Leu Leu Lou His Leu Asn Asp Ser Lys Ala Gin His Lou Arg Lys Ala
436 AAT TCT GTC CCC ACT CAA GCA TGT GM GCA AAC ATT TAC ACT TTA TTA TTG CAT TTG AAT GAT TCC MG GCA CAA CAT TTA CGA AAG GCA
176 Ser Val Pro Arg Leu lie Arg Asn lie Glu Phe Met Ser Phe Leu Ser Asp Pro lie Glu Lys Ile Ser Gin Glu Gly Ser His Tyr Trp
526 TCA GTG CCA AGG CTA ATT CGC AAC ATC GAG TTT ATG TCT TTT TTG TCA GAT CCA ATA GAA AM ATT TCT CM GAG GGA TCA CAT TAT TGG
206 Asn Ile Lou Ser Thr Trp Asp Phe Cys Ala Lou Ser Lou Ser Thr Gin Glu Leu Ile Trp Cys Gly Phe Thr Leu Ile Lys Lys Leu Ser
616 AAC ATT CTA TCA ACT TGG GAC TTT TGT GCT TTA TCA TTA AGC ACT CM GMA TTG ATT TGG TGC GGG TTC ACG CTT ATC MA MA TTA TCT
236 Lys Asp Ala Lys Val Leu Ile Ala Asp Asn Lys Leu Leu Leu Leu Leu Phe Thr Lou Glu Ser Ser Tyr His Gin Val Asn Lys Phe His
706 MG GAT GCA AAA GTA CTC ATT GCA GAT MT AMG TTA CTG CTA CTA CTA TTT ACT TTA GM TCA TCC TAT CAT CM GTT MC AAA TTT CAC
266 Asn Phe Arg His Ala Ile Asp Val Met Gin Ala Thr Trp Arg Leu Cys Thr Tyr Lou Leu Lys Asp Asn Pro Val Gin Thr Lou Lou Lou
796 AAT TTT AGG CAT GCC ATC GAT GTC ATG CM GCC ACA TGG CGA TTG TGT ACA TAT CTT CTT MA GAT MT CCT GTA CM ACA TTA CTG TTG
296 Cys Met Ala Ala Ile Gly His Asp Val Gly His Pro Gly Thr Asn Asn Gin Lou Lou Cys Asn Cys Glu Ser Glu Val Ala Gin Asn Phe
886 TGT ATG GCT GCC ATA GGT CAT GAT GTC GGT CAT CCT GGG ACT MC AAT CM CTA TTG TGC MC TGT GM TCA GAG GTT GCT CAA AAT TTC
326 Lys Asn Vol Ser Ile Leu Glu Asn Phe His Arg Glu Leu Phe Gin Gin Leu Leu Ser Glu His Trp Pro Lou Lys Lou Ser Ile Ser Lys
976 AAA AMT GTC TCT ATC TTG GAG MT TTT CAC AGG GM TTA TTT CAA CM TTG CTA TCA GAG CAT TGG CCT CTT MG CTC TCT ATC TCC AAA
356 Lys Lys Phe Asp Phe lie Ser Glu Ala lie Leu Ala Thr Asp Met Ala Lou His Ser Gin Tyr Glu Asp Arg Lou Met His Glu Asn Pro
1066 AAA AAA TTT GAT TTT ATT TCC GAG GCT ATT CTG GCC ACA GAT ATG GCA TTG CAT TCT CAG TAT GAG GAT AGA TTA ATG CAT GAA AAC CCA
386 Met Lys Gin Ile Thr Lou Ile Ser Leu loe ole Lys Ala Ala Asp lie Ser Asn Val Thr Arg Thr Leu Ser lie Ser Ala Arg Trp Ala
1156 ATG MA CM ATC ACT TTG ATA TCT CTA ATT ATT MA GCT GCA GAC ATC TCT MT GTG ACG AGA ACC TTG TCA ATA TCA GCA CGT TGG GCA
416 Tyr Leu Ile Thr Lou Glu Phe Asn Asp Cys Ala Leu Leu Glu Thr Phe His Lys Ala His Arg Pro Glu Gin Asp Cys Phe Gly Asp Ser
1246 TAC CTC ATT ACT CTC GAA TTT MT GAT TGC GCT CTT TTG GAA ACA TTT CAT MA GCT CAC CGC CCA GM CAM GAC TGT TTT GGC GAT TCA
446 Tyr Lys Asn Val Asp Ser Pro Lys Glu Asp Lou Glu Ser Ile Gin Asn Ile Lou Val Asn Vol Thr Asp Pro Asp Asp Ile lIe Lys Asp
1336 TAC MG MT GTT GAT TCT CCG MA GM GAT TTG GCA TCA ATT CAA MT ATT TTG GTG MC GTA ACA GAC CCT GAT GAT ATT ATC MA GAC
476 His Pro His lie Pro Asn Gly Gin Ile Phe Phe Ile Asn Thr Phe Ala Glu Vol Phe Phe Asn Ala Leu Ser Gin Lys Phe Ser Gly Lou
1426 CAT CCG CAT ATT CCA MC GGT CAAATITTT TTC ATT MT ACG TTT GCT GM GTA TTT TTC MC GCA TTA AGT CM MA TTC TCA GGA TTA
506 Lys Phe Lou Ser Asp Asn Vol Lys Ile Asn Lys Glu Tyr Trp Met Lys His Lys Lys Pro Gin ***
1516 AAA TTT TTA AGC GAT AAT GTC A ATC MT AMA C TAC TGG ATG A CAC MCG A CCA CAA TAGCAAGMATATCAATTTCTTGTACCATTCATT
1614 GTATMACATATMATATATACATTTACTACTAGTATA
FIG. 2. Nucleotide sequence of the PDE2 gene and deduced amino acid sequences of its gene product. The nucleotide sequence was obtained
by the strategy shown in Fig. 1c. There is one open reading frame. Coordinates on the left indicate nucleotide and amino acid positions. Asterisks
indicate termination codons.
of activity in extracts of wild-type cells that eluted at 0.090M
NaCl (Fig. 3A); and (ii) a larger peak of activity is strain
PS1-iBY, which contains a high-copy plasmid carrying the
Table 2. Comparison of amino acid compositions of the
low-affinity and the high-affinity cAMP PDEases and the
heat shock suppressor of RAS2Vall9
Amino Low affinity* High affinityt PDE2
acid No. Mol % No. Mol % No. Mol %
Asx 39 10.5 71.3 13.5 69 13.1
Thr 20 5.4 25.3 4.8 25 4.8
Ser 28 7.5 39.7 7.5 41 7.8
Glx 47 12.7 59.6 11.3 55 10.5
Pro 21 5.7 26 4.9 18 3.4
Gly 23 6.2 14.4 2.7 14 2.7
Ala 13 3.5 24 4.6 25 4.8
Val 21 5.7 26 4.9 26 4.9
Met 1 0.2 5.1 0.9 10 1.9
Cys ND - 5.1 0.9 11 2.1
Ile 26 7.0 39.7 7.5 42 8.0
Leu 44 11.9 61.7 11.7 61 11.6
Tyr 13 3.5 11.0 2.1 13 2.5
Phe 15 4.0 29.5 5.6 31 5.9
Lys 25 6.7 33.6 6.4 33 6.3
His 13 3.5 24 4.6 25 4.8
Trp 6 1.6 11 2.1 8 1.5
Arg 16 4.3 19.2 3.6 19 3.6
Data for the low- and high-affmity PDEases were derived from
purified protein (25, 26) whereas data for the heat shock suppressor
were deduced from the nucleotide sequence. ND, not determined.
*From ref. 25.
tFrom ref. 26.
PDE2 gene (Fig. 3B); but no peak of activity is seen in the
isogenic strain PS1-iBYL, which lacks the PDE2 gene (Fig.
3C). This result is consistent with the hypothesis that PDE2
encodes a cAMP PDEase.
To demonstrate that PDE2 encodes the PDEase with high
affinity for cAMP the initial rate of cAMP hydrolysis was
measured as a function of cAMP concentration using the
peak fraction from the DEAE-Sephacel column. The Line-
weaver-Burk plot of these data (Fig. 4) indicates a Km of 1.0
x 10-6 M, in good agreement with the data of Suoranta and
Londesborough (26), who analyzed the high-affinity cAMP
PDEase of yeast.
In all of our strains, including those lacking PDE2, it was
apparent that there was a residual PDEase activity present in
high concentrations of cellular extracts. This was presumably
due to the presence of large amounts of a low-affinity form of
cAMP PDEase, which has been reported by Uno et al. (20)
and must be encoded by a separate gene. We do not present
any data on this type of activity.
Phenotypic Consequences of Perturbation of PDE2. As
indicated above, the PDE2 gene was selected by its ability to
restore heat shock resistance to cells containing RAS2va'19.
This effect is demonstrated in Fig. 5, in which four types of
strains are compared. Strain SP1-YEp13 was a control strain
derived from SP1 by transformation and contained the LEU2
YEp13 vector alone. Strain SP1-PDE2 was another control
strain derived from SP1 and contained the PDE2 gene on the
high-copy LEU2 plasmid YEp13. Strain R2V-YEpl3 was a
control strain derived from the RAS2v`l9-containing strain
TK161-R2V by transformation with plasmid YEp13. Strain
R2V-PDE2 was the experimental strain derived from TK161-
R2V by transformation with the high-copy plasmid contain-
ing the PDE2 gene, YEpPDE2-1. These strains were inocu-
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prototrophic marker, as described above. Diploids were then
examined by Southern blotting to determine whether the
prototrophic marker had integrated within a single PDE2
locus. Several diploid strains were thus obtained and one was
subject to tetrad analysis. The results indicate that there is no
loss of viability in spores lacking the PDE2 gene (data not
shown). Finally, we examined the effect of high copy of the
PDE2 gene on the phenotype of wild-type S. cerevisiae by
transforming strain SP1 with plasmid YEpPDE2-1. Such
transformants grow more slowly than the parental strain in
synthetic medium but show no difference in heat shock
sensitivity or glycogen accumulation (data not shown).
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FIG. 3. DEAE-Sephacel column profiles of PDEase activity. (A)
Wild-type strain, SP1 (75 mg of protein). (B) Strain PS1-1BY
containing the high-copy PDE2 plasmid (25 mg of protein). (C) Strain
PS1-1BYL disrupted at the PDE2 locus (100 mg of protein).
lated onto synthetic medium lacking leucine (Fig. 5A) and
replica plated onto solid medium preheated to 55TC. They
were maintained at this temperature for 30 min, allowed to
cool, and then incubated at 30'C. In these experiments, the
density of the cell patch that regrows indicates the degree of
resistance to heat shock (Fig. SB). The RAS2vali9 strain was
clearly sensitive to heat shock but the RASP"2va9 cells with the
high-copy PDE2 appeared as resistant to heat shock as the
wild-type cells.
Another phenotype of cells containing the RAS2vali9 allele
is sensitivity to starvation. To test whether PDE2 reverses
this phenotype, the strains described above were treated as
follows. Cells were inoculated onto synthetic medium and
then replica plated onto nitrogen-lacking synthetic medium.
After 7 days, cells were replica plated back onto rich medium
and allowed to grow at 30'C. The results indicate that the
presence of the PDE2 gene on a high-copy plasmid restores
the ability of cells containing RAS2va'i9 to survive prolonged
nitrogen starvation (Fig. SC).
We examined the effect of loss of the PDE2 gene on cell
viability. For this purpose, we transformed a diploid cell with
a fragment of the PDE2 gene disrupted by the URA3
1/cAMP, (/AM)-'
FIG. 4. Lineweaver-Burk plot of ac-
tivity of the DEAE-Sephacel-purified
cAMP PDEase from strain PS1-iBY.
Fraction 30 from the DEAE-Sephacel
column (0.21 ,ug of protein) was assayed
for PDEase activity. [3H]cAMP (1000
cpm/pmol) concentrations were varied
from 0.25 to 10 AM. Two determinations
were made for each concentration of
cAMP. v, Velocity is expressed in pmol
of cAMP hydrolyzed in 30 min. Two
separate experiments gave a calculated
Km of 1.0 x 10-6M.
DISCUSSION
Cells containing the RAS2Va'19 mutation fail to accumulate
glycogen when they reach growth saturation, are unable to
arrest properly in an unbudded state when starved, show an
unusual sensitivity to starvation (8), and fail to become heat
shock resistant when they reach stationary growth phase
(unpublished data and this paper). We attribute these defects
to an inability of RAS2vall9 cells to enter a G1 growth arrest
state. We have developed methods for cloning genes that in
high copy reverse the phenotypes due to the RAS2vali9
mutation. One such gene is PDE2, which encodes a cAMP
PDEase. We have previously shown that the RAS genes are
essential controlling components of yeast adenylate cyclase
(7, 8) and that cells with the RAS2vali9 allele have elevated
cAMP levels (8). Overexpression of the cAMP effector
pathway because of high level expression of adenylate
cyclase (7), or because of overexpression of the catalytic
subunit of cAMP-dependent protein kinase (our unpublished
data), or because of deletion of the regulatory subunit of
cAMP-dependent protein kinase leads to the same set of
phenotypes as the RAS2Vall9 mutation (7, 27). These findings
together strongly suggest that many, if not all, of the
phenotypic abnormalities of RAS2vali9 are mediated through
its elevation of cAMP. The cloned cAMP PDEase gene may
provide a useful experimental tool for exploring the role of
cAMP in other eukaryotic cells.
A variety of forms of cAMP PDEases have been reported
in eukaryotic cells, including high-affinity and low-affinity
forms, forms having broad and narrow specificity, and forms
that are stimulated by various cofactors such as calmodulin
and cGMP (28, 29). Two cAMP PDEase activities have been
described in yeast: a low-affinity form having broad speci-
ficity and a high-affinity form having narrow specificity (25,
26). The high-affinity form is a zinc-requiring enzyme, with a
Km for cAMP of 1 x 10-6 M, and fails to hydrolyze cGMP
(26). It has an amino acid composition similar to that which
we predict for the PDE2-encoded product. Indeed, we have
shown that the PDE2 gene of the yeast S. cerevisiae appears
to encode a high-affinity cAMP PDEase. Gene disruption
experiments indicate that the PDE2 gene is not essential for
viable haploid yeast. This, presumably, is because yeast
contain a second, low-affinity cAMP PDEase. Indeed, we
detect considerable cAMP hydrolysis in crude extracts of
cells containing disrupted forms of the PDE2 gene. We do not
know whether yeast cells lacking both PDEases would be
viable. Sequence data have been obtained for a Drosophila
high-affinity cAMP PDEase, a calmodulin-stimulated PDE-
ase from bovine brain, and a cGMP-stimulated cAMP
PDEase from bovine heart (30, 31). Comparison of these
sequences with the sequence predicted from the yeast PDE2
gene reveals multiple regions of homology [these data will be
discussed by Charbonneau et al. (31)]. However, comparison
of the conserved sequences in the PDEase proteins with the
mammalian regulatory subunits of cAMP-dependent protein
kinase (32, 33), the regulatory subunit of the cAMP-depen-
dent protein kinase of yeast (our unpublished data), the
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FIG. 5. Heat shock and starvation phenotypes. Four yeast strains were tested for sensitivity to heat shock (B) or to starvation (C) by a
replica-plating method. (A) The master plate was inoculated with patches from four strains: SP1-YEp13, upper left; SP1-PDE2, upper right;
R2V-YEp13 (RAS2va`l9 strain; lower left); and R2V-PDE2, lower right. (B) The plate was heated to 550C for 1 hr, and then cells were replica
plated to it from the master plate and incubated at 550C for 30 min, and at 30'C for 48 hr. (C) The master plate was replica plated to a plate that
lacked a source of nitrogen, and this plate was incubated at 30'C for 7 days, then replica plated to a rich plate, which was incubated for 2 days
at 30'C.
cAMP binding protein ofE. coli (34), and the yeast adenylate
cyclase gene (7) show no regions of significant homology.
Since these proteins, with the exception of the yeast adenyl-
ate cyclase gene, contain a region that is highly conserved
and thought to be important in cAMP binding, it is interesting
that the PDE2 gene lacks this nucleotide binding region. Thus
it is not clear which sequence of the PDE2-encoded protein
can recognize cAMP.
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